PA
Perceptive Advisors Portfolio holdings
AUM
$5.06B
1-Year Est. Return
314.02%
This Fund
S&P 500
1 Year Est. Return
+314.02%
AUM
$5.06B
AUM Growth
-$396M
(-7.3%)
Holding
136
Top Buys
| 1 | +$101M | |
| 2 | +$70.2M | |
| 3 | +$59.9M | |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$39.8M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$33.2M |
Top Sells
| 1 | +$122M | |
| 2 | +$95.6M | |
| 3 | +$93.3M | |
| 4 |
FOLD
Amicus Therapeutics
FOLD
|
+$90.7M |
| 5 |
ATXS
Astria Therapeutics
ATXS
|
+$84.9M |
Sector Composition
| 1 | Healthcare | 99.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CytomX Therapeutics
CTMX
$703M
| $47.5M | 0.94% |
10,098,824
+418,639
|
|
||
27
Alto Neuroscience
ANRO
$656M
| $45.2M | 0.89% |
2,009,893
+225,500
|
|
||
28
enGene Therapeutics
ENGN
$114M
| $39.7M | 0.78% |
5,827,506
-41,570
|
|
||
29
Immunovant
IMVT
$6.31B
| $39.7M | 0.78% |
1,597,383
-397,507
|
|
||
30
Intuitive Surgical
ISRG
$142B
| $39.4M | 0.78% |
85,419
-2,500
|
|
||
|
31
Ionis Pharmaceuticals
IONS
$12.1B
| $37.8M | 0.75% |
+504,000
|
|
||
|
DAWN
32
DELISTED
Day One Biopharmaceuticals
DAWN
| $37.6M | 0.74% |
+1,755,799
|
|
||
|
ABVX
33
Abivax
ABVX
$6.58B
| $36.6M | 0.72% |
328,884
-129,459
|
|
||
34
Corvus Pharmaceuticals
CRVS
$971M
| $33.5M | 0.66% |
2,292,441
+1,600,000
|
|
||
35
Repligen
RGEN
$6.87B
| $33.1M | 0.65% |
280,541
-35,000
|
|
||
36
Jazz Pharmaceuticals
JAZZ
$14.5B
| $32.1M | 0.63% |
170,000
|
|
||
|
DMRA
37
Damora Therapeutics
DMRA
$1.37B
| $31.7M | 0.63% |
+1,223,000
|
|
||
38
X4 Pharmaceuticals
XFOR
$385M
| $27.8M | 0.55% |
6,737,648
+423,196
|
|
||
39
Guardant Health
GH
$17B
| $27.7M | 0.55% |
300,000
+140,000
|
|
||
|
DRUG
40
Bright Minds Biosciences
DRUG
$767M
| $27.5M | 0.54% |
377,544
-71,746
|
|
||
41
Invivyd
IVVD
$327M
| $27.1M | 0.54% |
20,859,303
-925,863
|
|
||
|
SION
42
Sionna Therapeutics
SION
$1.62B
| $26.4M | 0.52% |
658,439
-520,659
|
|
||
43
Axsome Therapeutics
AXSM
$11.8B
| $25.3M | 0.5% |
149,950
+1,050
|
|
||
44
Revolution Medicines
RVMD
$32.7B
| $25.1M | 0.5% |
+258,600
|
|
||
45
SAB Biotherapeutics
SABS
$255M
| $24.6M | 0.49% |
6,431,743
+5,628,533
|
|
||
|
BLTE
46
Belite Bio
BLTE
$5.44B
| $24.2M | 0.48% |
151,979
-262,260
|
|
||
47
Tenax Therapeutics
TENX
$295M
| $23.2M | 0.46% |
1,447,782
+1,008,640
|
|
||
48
Axogen
AXGN
$2.1B
| $23.1M | 0.46% |
697,312
-86,828
|
|
||
49
Viridian Therapeutics
VRDN
$1.8B
| $22.9M | 0.45% |
1,170,829
-1,871,874
|
|
||
50
Orchestra BioMed
OBIO
$228M
| $21.4M | 0.42% |
5,037,906
-89,350
|
|